Skip to content
Info@spinogenix.comMonday – Friday 10 AM – 8 PM
Linkedin page opens in new windowX page opens in new windowInstagram page opens in new windowVimeo page opens in new windowYouTube page opens in new window
Spinogenix
Restoring Synaptic Function Starts Today
SpinogenixSpinogenix
  • About
    • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
  • Patients
    • Patients
    • Expanded Access Policy
  • Media
    • Press Releases
    • In The News
    • Blog
  • Contact
Search:
  • About
    • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
  • Pipeline
  • Patients
    • Patients
    • Expanded Access Policy
  • Media
    • Press Releases
    • In The News
    • Blog
  • Contact

Amyotrophic Lateral Sclerosis (ALS)

World first drug trial for MND treatment

By willJanuary 16, 2023
←1234←
©2026. Spinogenix, Inc. All rights reserved.    |   Privacy Policy   |   Accessibility Policy   |   Disclaimer   |   EAP   |   
Website developed by Insight Designs Web Solutions, LLC
Go to Top